480 related articles for article (PubMed ID: 11224484)
1. Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping.
Wuchter C; Ratei R; Spahn G; Schoch C; Harbott J; Schnittger S; Haferlach T; Creutzig U; Sperling C; Karawajew L; Ludwig WD
Haematologica; 2001 Feb; 86(2):154-61. PubMed ID: 11224484
[TBL] [Abstract][Full Text] [Related]
2. [Expression of AC133 vs. CD34 in acute childhood leukemias].
Ebener U; Brinkmann A; Zotova V; Niegemann E; Wehner S
Klin Padiatr; 2000; 212(3):90-8. PubMed ID: 10916777
[TBL] [Abstract][Full Text] [Related]
3. Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1.
Wuchter C; Harbott J; Schoch C; Schnittger S; Borkhardt A; Karawajew L; Ratei R; Ruppert V; Haferlach T; Creutzig U; Dörken B; Ludwig WD
Leukemia; 2000 Jul; 14(7):1232-8. PubMed ID: 10914547
[TBL] [Abstract][Full Text] [Related]
4. Immunologic purging of autologous peripheral blood stem cell products based on CD34 and CD133 expression can be effectively and safely applied in half of the acute myeloid leukemia patients.
Feller N; van der Pol MA; Waaijman T; Weijers GW; Westra G; Ossenkoppele GJ; Schuurhuis GJ
Clin Cancer Res; 2005 Jul; 11(13):4793-801. PubMed ID: 16000576
[TBL] [Abstract][Full Text] [Related]
5. AC133 antigen as a prognostic factor in acute leukemia.
Lee ST; Jang JH; Min YH; Hahn JS; Ko YW
Leuk Res; 2001 Sep; 25(9):757-67. PubMed ID: 11489469
[TBL] [Abstract][Full Text] [Related]
6. Positive selection for CD90 as a purging option in acute myeloid leukemia stem cell transplants.
Feller N; Kelder A; Westra G; Ossenkoppele GJ; Schuurhuis GJ
Cytometry B Clin Cytom; 2008 Jan; 74(1):9-16. PubMed ID: 18061946
[TBL] [Abstract][Full Text] [Related]
7. AC133 expression in egyptian children with acute leukemia: impact on treatment response and disease outcome.
Elgendi HM; Mekawy MA; Abdel Wahab SE; Tawfik LM; Ismail EA; Adly AA
J Pediatr Hematol Oncol; 2010 May; 32(4):286-93. PubMed ID: 20224439
[TBL] [Abstract][Full Text] [Related]
8. CD133-2 (AC141) expression analysis in acute leukemia immunophenotyping in correlation to CD34 and P-glycoprotein.
Guenova M; Balatzenko G
Hematology; 2008 Jun; 13(3):137-41. PubMed ID: 18702870
[TBL] [Abstract][Full Text] [Related]
9. CD45
Heo SK; Noh EK; Ju LJ; Sung JY; Jeong YK; Cheon J; Koh SJ; Min YJ; Choi Y; Jo JC
BMC Cancer; 2020 Apr; 20(1):285. PubMed ID: 32252668
[TBL] [Abstract][Full Text] [Related]
10. [The expression and clinical significance of early differentiation antigens in acute leukemia].
Zhou Y; Li Q; Meng HX; Wang YF; Yu Z; Qiu LG
Zhonghua Nei Ke Za Zhi; 2005 Jan; 44(1):46-9. PubMed ID: 15769398
[TBL] [Abstract][Full Text] [Related]
11. [Expression of CD133 in bone marrow cells of patients with leukemia and myelodysplastic syndrome].
Wang W; Wang HY; Zhao HX; Cui ZG; Li GL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):470-3. PubMed ID: 17605847
[TBL] [Abstract][Full Text] [Related]
12. AC133 expression on acute myeloid leukemia blasts: correlation to FAB and to CD34 expression and possible implications for peripheral blood progenitor cell purging in AML.
Fauth F; Weidmann E; Martin H; Schneider B; Sonnhoff S; Hoelzer D
Leuk Res; 2001 Mar; 25(3):191-6. PubMed ID: 11226513
[TBL] [Abstract][Full Text] [Related]
13. CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and nonhematopoietic origin.
Bühring HJ; Kuçi S; Conze T; Rathke G; Bartolović K; Grünebach F; Scherl-Mostageer M; Brümmendorf TH; Schweifer N; Lammers R
Stem Cells; 2004; 22(3):334-43. PubMed ID: 15153610
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotypic differences between putative hematopoietic stem cells and childhood B-cell precursor acute lymphoblastic leukemia cells.
Lamkin T; Brooks J; Annett G; Roberts W; Weinberg K
Leukemia; 1994 Nov; 8(11):1871-8. PubMed ID: 7526089
[TBL] [Abstract][Full Text] [Related]
15. [The expression of CD133 in acute leukemia and its clinical significance].
Zhou Y; Meng HX; Yu Z; Li Q; Wang YF; Mai YJ; Han JL; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):401-4. PubMed ID: 15355691
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric analysis of Thy-1 expression in CD34-positive acute leukemia.
Inaba T; Shimazaki C; Sumikuma T; Takahashi R; Hirai H; Kikuta T; Sudo Y; Yamagata N; Ashihara E; Goto H; Fujita N; Yoshimura M; Nakagawa M
Int J Hematol; 1997 Oct; 66(3):315-23. PubMed ID: 9401277
[TBL] [Abstract][Full Text] [Related]
17. [Expression of two subtype molecules of CD133 in childhood with B linage acute lymphoblastic leukemia and its clinical significance].
Zhao WL; Nie SS; Xu YY; Zhang YL; Guo DD; Pan J; Wang JM; Zhang XG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):536-40. PubMed ID: 22739150
[TBL] [Abstract][Full Text] [Related]
18. CD117/CD34 expression in leukemic blasts.
Wells SJ; Bray RA; Stempora LL; Farhi DC
Am J Clin Pathol; 1996 Aug; 106(2):192-5. PubMed ID: 8712172
[TBL] [Abstract][Full Text] [Related]
19. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
[TBL] [Abstract][Full Text] [Related]
20. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
